BARCLAYS PLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 154 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$804
-15.6%
126,628
-19.5%
0.00%
Q1 2024$953
-32.3%
157,377
-32.2%
0.00%
-100.0%
Q4 2023$1,408
+496.6%
232,020
+313.1%
0.00%
Q3 2023$236
+29.0%
56,168
-5.0%
0.00%
Q2 2023$183
+52.5%
59,147
-32.0%
0.00%
Q1 2023$120
-3.2%
86,993
+39.1%
0.00%
Q4 2022$124
-99.8%
62,542
+59.3%
0.00%
Q3 2022$79,000
-61.5%
39,256
-39.3%
0.00%
Q2 2022$205,000
-24.9%
64,685
-1.6%
0.00%
Q1 2022$273,000
-84.6%
65,745
-82.2%
0.00%
Q4 2021$1,772,000
+400.6%
370,046
+458.7%
0.00%
Q3 2021$354,000
+185.5%
66,233
+170.8%
0.00%
Q2 2021$124,000
-84.5%
24,455
-79.5%
0.00%
Q1 2021$802,000
+65.4%
119,168
+12.3%
0.00%
Q4 2020$485,000
-4.5%
106,119
-18.8%
0.00%
Q3 2020$508,000
-26.2%
130,739
-9.5%
0.00%
-100.0%
Q2 2020$688,000
+59.6%
144,458
+16.5%
0.00%
Q1 2020$431,000
-36.2%
123,976
-11.5%
0.00%
Q4 2019$676,000
+241.4%
140,144
+105.8%
0.00%
Q3 2019$198,000
-89.8%
68,093
-74.7%
0.00%
-100.0%
Q2 2019$1,933,000
+134.9%
269,639
+364.3%
0.00%0.0%
Q1 2019$823,000
+4472.2%
58,077
+4279.9%
0.00%
Q4 2018$18,000
-98.1%
1,326
-96.9%
0.00%
-100.0%
Q3 2018$953,000
-84.2%
42,951
-88.3%
0.00%
-80.0%
Q2 2018$6,041,000368,1560.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Fosun International Ltd 19,552,001$433,859,00020.80%
BRIDGER MANAGEMENT, LLC 2,642,621$58,640,0003.39%
TPG Group Holdings (SBS) Advisors, Inc. 3,884,600$86,199,0001.10%
HUSSMAN STRATEGIC ADVISORS, INC. 125,000$2,774,0000.80%
HealthCor Management, L.P. 1,036,110$22,991,0000.76%
GW&K Investment Management, LLC 2,049,765$45,484,0000.73%
Bridge City Capital, LLC 50,434$1,119,0000.70%
TCW GROUP INC 2,521,064$55,942,0000.46%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,876,367$63,827,0000.41%
Quadrant Capital Management, LLC 25,002$555,0000.35%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders